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ABSTRACT 
Obstructive sleep apnea (OSA)- the occurrence of repetitive episodes of airway 
obstruction during sleep- is considered a major health problem affecting up to 9% of 
adults in the United States (Parish & Somers, 2004). The hypoglossal motor nucleus 
(HMN) controls genioglossus muscle tone and is critically important for maintaining 
airway patency; loss of excitatory input to the HMN during sleep results in disfacilitation 
of hypoglossal motoneurons, increased airway resistance and contributes to the 
development of OSA (Horner R. L., 2007). However, a fundamental question of sleep 
medicine that remains unresolved is what mechanisms help maintain airway patency 
during sleep? A potential source of sleep-activated compensatory drive is nitric oxide 
released from cholinergic terminals in the HMN (Pose et al. 2005; Vincent & Kimura, 
1992). Here we show that NO functions as an excitatory transmitter in the HMN by a 
cGMP-dependent inhibition of a background TASK-like conductance and an S-
nitrosylation-dependent activation of the instantaneous but not the time-dependent 
component of the hyperpolarization-activated current (Ih) generated by 
hyperpolarization-activated cyclic nucleotide gated (HCN) channels. These results 
suggest that sleep-induced nitrergic innervation of the HMN helps compensate for 
respiratory motoneuron disfacilitation and disruption of NO/cGMP signaling may 
contribute to the etiology of OSA. Although a causal link between disruption of 
NO/cGMP signaling and occurrence of OSA has yet to be established, it is well known 
that patients with metabolic syndrome have high levels of uric acid- a potent NO 
scavenger- and, perhaps consequently, are at much higher risk of developing OSA 
(Mota, 2010). 
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INTRODUCTION 
 Obstructive sleep apnea (OSA) is a problem that is on the rise year after year. 
Individuals with this health problem have repeated bouts of asphyxia because of upper 
airway narrowing and closure. Around 9% of the population suffers from OSA with a 
great deal of cases going undiagnosed (Grunstein et al. 2001). It is often cited as a 
comorbidity with stroke, cardiovascular disease and daytime somlence (Smith & 
Quinnell, 2004). The cause of OSA is not known but is thought to result in part from 
fundamental changes in upper airway motoneuron function during sleep. The awake-
sleep state dependent control of airway motoneurons is poorly understood and thus 
pharmacological strategies designed to treat sleep apnea have been largely 
unsuccessful (Grunstein et al. 2001; Smith & Quinnell, 2004; Veasey et al. 2006).  As 
part of my thesis work I identity a novel mechanism by which nitric oxide (NO), released 
during sleep, modulates the activity of respiratory motoneurons and in doing so offers 
new potential therapeutic targets for the treatment of OSA. 
 The hypoglossal motor nucleus (HMN) controls genioglossus muscle (tongue) 
tone and is critically important for maintaining upper airway patency; loss of this tone 
increases airway resistance and therefore contributes to the development of OSA 
(Horner, 2007). During wakefulness the HMN receives tonic serotonergic (5HT) and 
noradrenergic (NE) drive. It is well established that these neurotransmitters increase 
excitability of hypoglossal motoneurons, in part, by activation of G-protein coupled 
receptors (GPCRs) linked to the Gαq subunit inhibition of the TWIK-related acid-
sensitive K+ (TASK) member of the KNCK family of background K+ channels (Abudara 
et al. 2002; Ahern et al. 2002). Activation of hyperpolarization activated cyclic nucleotide 
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gated channels (HCN) is mediated by NE stimulating adenylate cyclase (AC) which 
increases cAMP causing a shift in activation to more depolarized potentials (Walh-
Schott & Biel, 2009). It has also been shown that AC stimulation can increase cAMP 
which can then activate protein kinase A (PKA). PKA may phosphorylate HCN channels 
directly to increase their activity in the SA node of the heart (Larsson, 2010).  
 In the brain, the majority of this excitatory input is lost during sleep resulting in 
disinhibition of TASK channels and loss of motoneuron activity, a process referred to as 
disfacilitation (Horner, 2000; Horner, 2006). The normal process of disfacilitation results 
in a narrowing of the airway, but it is not the only variable that leads to OSA. The focus 
of my thesis work is to explore the potential neuronal mechanisms that help keep the 
upper airway in a state of patency during sleep, thus rendering OSA more likely to be 
treated with novel pharmacological agents.  
 It has been shown that components of the sleep-activated cholinergic system 
project to the HMN and express high levels of neuronal nitric oxide synthase (nNOS) in 
terminals near hypoglossal neurons (Montero et al. 2008). Neuronal NOS will generate 
and release NO in an activity dependent manner (Williams, Vincent, & Reiner, 1997). 
However, levels of NO in the HMN have not been measured and a physiological role of 
NO in control of respiratory motoneurons has not fully understood. It is well known that 
nitric oxide (NO) can modulate neuronal activity by either activation of soluble guanylate 
cyclase (sGC) with the formation of cGMP or by a cGMP-independent pathway 
conferred by S-nitrosylation (Abudara et al. 2002; Ahern et al. 2002). I propose that NO 
compensates for loss of excitatory drive during sleep by activating hypoglossal 
motoneurons. I will use slice-patch electrophysiological techniques to determine if NO 
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functions as an excitatory transmitter in the HMN and to identify the signaling pathway 
(i.e., cGMP-dependent and/or –independent mechanisms) and downstream ion channel 
targets mediating NO-sensitivity. 
BACKGROUND 
 The upper airway extends from the nasopharynx to the epiglottis and is 
supported primarily by the activity of pharyngeal skeletal muscles. The genioglossus 
muscle (GG) of the tongue is the largest upper airway dilator muscle; contraction of 
which results in anterior movement of the tongue and widening of the oropharyngeal 
airway (Kubin et al. 1998). Hypoglossal motoneurons innervate the GG and so their 
activity determines the position, shape and tone of the tongue. As such, the hypoglossal 
motor nucleus (HMN) is the principle focus for basic research aimed at understanding 
control of upper airway function.  
 The HMN receives inspiratory drive from pre-motor neurons in brainstem 
respiratory centers in order to counteract negative airway pressure generated during 
inspiration. This respiratory drive is mediated by glutamate acting on postsynaptic 
alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptors 
(Bocchiaro et al. 2003; Funk et al. 1997; Funk et al. 1993) and is considered relatively 
stable across sleep-wake cycles (Horner, 2007). In the absence of inspiratory drive (i.e., 
between breathes), upper airway diameter is determined primarily by tonic excitatory 
drive mediated by 5HT, thyrotropin-releasing hormone (TRH), substance P (SP) and NE 
(Kubin et al. 1998). Hypothalamic neurons also contribute to vigilance by releasing 
orexin throughout the neuroaxis, including the HMN (Sakurai, 2007). The effects of 
these neurotransmitters are well characterized, and collectively been shown to increase 
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hypoglossal activity through activation of Gαq subunit of G-protein coupled receptors 
inhibition of TASK channels (Bayliss et al.1994; Chen, et a l., 2006; Fenik & Veasey, 
2003; Mathie, 2007).   
 Tonic excitatory drive provided to the HMN is state dependent; raphe neurons 
(which release 5HT, TRH, SP), noradrenergic subcoeruleus and orexin-producing 
hypothalamic neurons are most active during wakefulness and minimally active during 
REM sleep (Aston-Jones & Bloom, 1981; Chan et al. 2006; Horner, 1996; Jacobs & 
Azmitia, 1992; Sakurai, 2007). Therefore, the onset of sleep initiates fundamental 
changes in the control of pharyngeal motoneurons that result in a loss of HMN activity, a 
decrease in responsiveness to glutamatergic inspiratory drive (Bellingham & Funk, 
2000) and suppression of pharyngeal reflexes (Fogel et al. 2003). These changes in 
motoneuron activity during sleep correspond with an increase i n airway resistance, 
development of hypoventilation and an increase in arterial PCO2 normally observed in 
sleeping humans (Horner, 2007; Kubin et al. 1998). In individuals with an already 
anatomically narrow upper airway, such as associated with obesity (Arens et al. 2003), 
the loss of pharyngeal muscle tone during sleep can cause airway obstruction and OSA 
(Horner, 1996; Horner, 2000;  Horner, 2007; Jordan & White, 2008; Kubin et al. 1998).  
 If OSA is a consequence of an otherwise normal process of motone uron 
disfacilitation then the condition should be amiable to pharmacological treatment.   
However, pharmacological strategies to compensate for disfacilitation by increasing 
tonic drive using 5HT or NE reuptake inhibitors, receptor specific agonists, or age nts 
that increase production or slow transmitter breakdown, have been largely unsuccessful 
(Smith & Quinnell, 2004). These observations suggest that factors in addition to sleep-
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induced loss of excitatory input to pharyngeal motoneurons contribute to the 
development of OSA. I hypothesize that the onset of sleep activates a compensatory 
mechanism that normally helps maintain airway patency by activating respiratory 
motoneurons through activation of HCN channels and inhibition of TASK channels. I 
propose that disruption of this mechanism will contribute to the development of OSA.   
 The collective loss of a wakeful stimulus (i.e., disfacilitation) to respiratory motor 
nuclei including the HMN is an enduring concept in respiratory medicine and is widely 
believed to be the primary mechanism of OSA (Horner, 1996; Horner, 2000; Horner, 
2007; Jordan & White, 2008; Kubin et al. 1998). Numerous pharmacological treatments 
have been proposed for the amelioration of sleep apnea symptoms, such as tricyclic 
antidepressants, SSRIs, sex steroids, theophylline and hypertensive agents, yet none 
have proven successful (Grunstein et al. 2001). One treatment viewed as the “gold 
standard” is continuous positive airway pressure (CPAP). CPAP was addressed as a 
treatment for sleep apnea in 1981 (Smith & Quinnell, 2004). The apparatus contains a 
mask that contours to the nose and occasionally mouth of the individual. The mask is 
connected to a pump that continually generates positive pressure allowing the airway to 
remain in a state of patency or openness (Smith & Quinnell, 2004). The positive 
pressure effectively acts as a splint to ensure less resistance to airflow. However, 
compliance with the system is often low often due to patient discomfort. In light of the 
complications involved with using a mechanical apparatus to resolve the problems 
associated with sleep apnea, novel pharmacological approaches seem preferable. This 
manuscript proposes nitric oxide as potentially one of those treatments.  
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 Nitric oxide (NO) is a potent neuromodulator involved in numerous physiological 
processes, such as sleep (Cavas & Navarro, 2006), memory (Esplugues, 2002) and 
respiratory control (Pierrefiche et al. 2007). The amino acid precursor L-arginine is 
needed to generate nitric oxide. Calcium dependent enzymes know as nitric oxide 
synthases (NOS) converts L-arginine into L-citrulline and nitric oxide (Gautier-Sauvigne 
et al. 2005). Three main isoforms of NOS are found within the body. Endothelial NOS 
(eNOS) is important in the relaxation of smooth muscle (Foster et al. 2003). Inducible 
NOS (iNOS) is expressed primarily by the immune system during times of inflammation 
and is the isoform that can function in a calcium independent manner (Calabrese et al. 
2007). The focus of the current study in the brainstem pertains to isoform neuronal nitric 
oxide synthase (nNOS) located in cholinergic terminals in the HMN.  
 Unlike most neurotransmitters, NO is not stored in synaptic vesicles and released 
by exocytosis, rather, nNOS generates NO in a Ca2+/calmodulin dependent manner and 
can readily diffuse and serve a paracrine function with neighboring cells. Therefore, 
synthesis of NO is key to regulating its activity. The main target of NO is the cytosolic 
enzyme soluble guanylyl cyclase (sGC). The sGC family has a multitude of isoforms, 
but NO predominately interacts with the α1β1 family (Murad, 2006). Upon NO binding, 
activation of sGC catalyzes the formation of cGMP from GTP (Ahern et al. 2002). Cyclic 
GMP (cGMP) initiates activation of three major types of downstream effectors. It could 
activate serine/threonine protein kinase G (PKG) which has been shown to contribute to 
the downstream effects of cGMP via phosphorylation (Ahern et al. 2002). cGMP also 
has an effect on cyclic nucleotide gated channels, including hyperpolarization-activated 
cyclic nucleotide-gated channels (HCN channels) that produce a hyperpolarization-
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activated cationic current (Ih) (Esplugues, 2002). Finally, cGMP levels effect 
phosphodiesterases (PDE) that serve to limit the level and type of nucleotides present 
in the cytosol. In addition, NO has also been shown to affect neuronal activity by a sGC-
independent mechanism conferred by direct protein S-nitrosylation (Ahern et al. 2002). 
S-nitrosylation is the process whereby cysteine thiols are modified via a reduction-
oxidation (REDOX) reaction by nitric oxide (Foster et al. 2003). My results will show that 
both cGMP-dependent and –independent signaling contribute to NO-modulation of 
hypoglossal motoneurons.   
 The HMN is known to express sGC and evidence suggests that under normal 
conditions the HMN receives NO innervation from the medullary reticular formation and 
pontine cholinergic neurons of the laterodorsal and pedunculopontine tegmental nuclei 
(LDT/PPT) (Gautier- Sauvigne et al. 2005; Pose et al. 2005). Activity of neurons in the 
LDT/PPT and medullary reticular formation are controlled by inhibitory influence of 5HT 
and NE producing neurons. During sleep, the progressive loss of 5HT and NE drive to 
the LDT/PPT results in withdrawal of inhibition. Subsequent activation of LDT/PPT 
neurons increases acetylcholine release into the pontine and medullary reticular 
formation to trigger REM sleep. In addition to these cholinergic effects on REM sleep, 
activation of the LDT/PPT and reticular formation has been shown to cause the activity-
dependent release of NO, e.g., nitrergic LDT projections to the thalamus release NO 
when stimulated or during REM sleep. NADPH-d studies further support this finding with 
varicosities localized near motoneurons in the hypoglossal nucleus (Montero et al. 
2008). However, levels of NO in the HMN have not been measured and a physiological 
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role of NO in state-dependent control of respiratory motoneurons has not been 
established. 
The exact molecular substrate conferring NO-sensitivity to hypoglossal 
motoneurons is not known at this time. There are several NO-sensitive voltage-
dependent K+ channels including KATP (Lei et al. 2004), Ca
2+ activated (Lei et al. 2004), 
(Dong, et al., 2007), delayed rectifier (Han et al. 2006) and transient K+ channels (Han 
et al. 2006). Cyclic nucleotide gated channels (CNG channels) may also represent 
common target of both arousal- and sleep-active signals.  
The hypoglossal motoneurons expresses a NO modulated family of channels, 
known as HCN channels. These channels produce a hyperpolarization-activated current 
(Ih) that consists of: a fast instantaneous current (Iinst) and a slowly developing steady 
state current (Iss). This is a mixed cationic conductance with a reversal potential around 
-35 mV (Walh-Schott & Biel, 2009). Hypoglossal neurons express HCN1 and HCN2 
channel subunits (Chen et al. 2005) and a prominent Ih current that can be activated by 
transmitters associated with wakefulness (e.g., 5HT, NE, TRH) (Walh-Schott & Biel, 
2009). The Iss component of Ih can be activated directly by cAMP and cGMP in a 
protein kinase independent manner (Walh-Schott & Biel, 2009). Cyclic nucleotides bind 
directly to the cyclic nucleotide binding domain (CNBD) on the C-linker domain with a 
resulting shift in the activation curve and opening kinetics (Seifert et al. 1999). Binding 
of cyclic nucleotides differ between cAMP which is in the anti conformation and cGMP 
which is in the syn conformation of the C-terminus (Craven & Zagotta, 2006). In cardiac 
pacemaker cells which also express high levels of HCN2, NO has been shown to 
increase heart rate by increasing Ih (Musialek et al. 1997). Importantly, drugs and both 
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cAMP and cGMP increase Iss. There is little evidence to date that Iinst can be 
differentially regulated as a neuromodulatory mechanism.   
 It has been shown that the instantanous component can be increased without 
changing the overall voltage dependence with application of the drug Tanshinone IIA 
(Liang et al. 2009). This occurred due to a slowing of the activation and deactivation 
kinetics of the channel and increasing the minimum open probability (Liang et al. 2009). 
There was a more pronounced effect on the HCN channel with slower open kinetics, 
such as HCN2 channels, which are highly expressed in the hypoglossal motoneuron 
population (Liang et al. 2009). However, the exact mechanism of the phenomenon has 
not yet been elucidated. In addition, coexpression of HCN2 with the accessory protein 
MiRP1 (KCNE), a β subunit that is involved in numerous voltage -gated potassium 
channels, was shown to increase the Iinst while also decreasing max Ih (Proenza et al. 
2002). These work support the concept that Ih and Iinst may be differentially modulated.  
As part of my thesis, I will present the first evidence that Iinst can be differentially 
regulated as a neuromodulatory mechanism involving S-nitrosylation. 
 Another potential method of NO modulation of channels is a post-translational 
modification though which NO can modulate proteins in a covelent manner directly, 
known as S-nitrosylation (figure 1). S-nitrosylation is a REDOX reaction involving 
oxidation of the thiol group on cysteine residues (Broillet, 1999). NO can mediate this 
reaction directly or via a nitrosium ion intermediate (Broillet, 1999). In either case, 
formation of the S-nitrosothiol (R-SNO) can confer conformational changes to the 
protein and thus change protein activity in a manner similar to other post-translational 
modifications including phosphorylation (Figure 1) (Gaston et al. 2003). S-nitrosylation  
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Figure 1. NO formation and modes of action. A, Formation of the nitrosonium ion 
(NO+) can bind to the thiol group (S-H) located on cysteine residues forming an S-
nitrosothiol. S-nitrosothiols can modulate channel activity. B, NO can bind to superoxide 
(O2-) forming reactive nitrogen species (RNS) like peroxynitrite. RNS can cause S-
nitrosylation of a multitude of targets. C, In aerobic conditions, NO can form nitrites and 
nitrogen dioxide. D, NO can bind to the enzyme soluble guanylyl cyclase (sGC) 
producing cGMP. This second messenger cGMP can activates channels, kinases and 
phosphodiesterases. E, NO can bind to transition metals. 
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can has been shown to increase and decrease the activity of other channels directly, 
such as, ryanodine receptors, NMDA receptors, cyclic-nucleotide-gated channels, Na+ 
channels, Ca2+-activated K+ (BK) channels, among others (Ahern, Klyachko, & Jackson, 
2002). 
 S-nitrosylation has also been shown to activate a family of channels structurally 
related to HCN, know as cyclic nucleotide gated channels (Broillet & Firestein, 1996). 
These channels share their origin from a family of voltage gated K+ channels with a 
tetrameric arrangement of proteins around a central pore (Walh-Schott & Biel, 2009). 
The transmembrane domain known as S4 contains the conserved voltage sensor which 
is more sensitive in HCN channels (Walh-Schott & Biel, 2009). The intracellular C-
terminus contains the CNBD connected to the S6 linker domain in both channels 
(Craven & Zagotta, 2006). This S6 linker domain is important because CNGs have been 
shown to be directly modulated by S-nitrosylation (Broillet & Firestein, 1996). In addition 
to the direct activation of CNG by S-nitrosylation, HCN has been shown to be a 
nitrosylation target via a biotinylation assay (Jaffrey et al. 2001). However, there is 
currently no evidence that S-nitrosylation has any direct effect on HCN channels. 
 CNG and HCN channels are closely related but serve different physiological 
functions. CNG channels are located primarily in senory regions, such as  
photoreceptors and neurons used in olfaction. These channels are voltage independent 
and rely on direct binding of cyclic nucleotides (Broillet & Firestein, 1996). In contrast, 
HCN channels are important for the firing rates of neurons, as well as pacemaker 
properties of the sinoatrial node in the heart. Their modulation is by cyclic nucleotides 
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such as cAMP, cGMP and also hyperpolarizing voltage changes (Craven & Zagotta, 
2006).  
 Another potential target of NO, are the KNCK family of two-pore or tandem pore 
domain (K2P) background K+ channels which are necessary to establish a negative 
membrane potential (Kim, 2005; Patel & Honore, 2001). Inhibition of these channels 
promotes membrane depolarization, whereas their activation induces hyperpolarization. 
Of the KNCK family of background K+ channels expressed in the brain, the only two that 
appear to be NO sensitive are TASK (Gonzalez-Forero et al. 2007) and TREK-1 (Dallas 
et al. 2008). There is also evidence that TALK-1 and TALK-2 are activated by NO 
(Duprat et al. 2005) but these background K+ channels are not expressed in the brain 
and so are excluded as candidates for the NO-sensitive current in hypoglossal neurons. 
It is well documented that hypoglossal neurons express high levels of TASK-1 and 
TASK-3 channels, and that neurotransmitters released during arousal increase activity 
of hypoglossal neurons by activation of Gαq linked receptors and inhibition of TASK -like 
K+ currents (Chen et al. 2006). The TASK family of channels are characterized as 
“leakage” channels based on their voltage and time independence.  Therefore, we 
consider TASK-1 and/or TASK-3 channels the most likely molecular substrate for 
determining NO-sensitive of the K+ component in hypoglossal neurons. 
  As mentioned previously, TASK channels are shown to be vitally important in 
activities like establishing resting membrane potential and altering cell excitability 
(Talley et al. 2000). There is some controversy on how TASK channels are modulated 
during wakefulness. Some studies implicate the involvement of PLC, as well as its 
products generated during hydrolysis, such as Phosphatidylinositol 4,5-bisphosphate 
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(PIP2) depletion or diacylglycerol (DAG) stimulation of Protein Kinase C (PKC) (Mathie, 
2007). A recent study provides evidence of a direct modulation of TASK channels by the 
Gαq subunit of the activated GPCR (Chen et al., 2006). Experiments conducted in this 
paper provide compelling evidence that PIP2 depletion can occur with no change in 
TASK conductance. Direct modulation was also shown via coimmunoprecipitation of the 
Gαq subunit of the GPCR and the TASK1-TASK3 heterodimer (Berg et al. 2004).  
 The physiological consequence of nitrergic drive to the HMN is not known. A 
recent in vivo study found that inhibition of endogenous NOS or sGC in the HMN 
decreased activity of hypoglossal neurons, whereas application of NO donors or a cell 
permeable and non-hydrolysable cGMP analog (8-Br-cGMP) increased activity of 
hypoglossal neurons (Gonzalez-Forero et al. 2007). In the brain slice, whole-cell 
recordings from guinea pig trigeminal neurons show that NO donors and cell permeable 
analog of cGMP both increase excitability with no change in input resistance, possibly 
by activating HCN channels and increased Ih, in addition to inhibiting the TASK 
component (Abudara et al. 2002). Similar results were observed in rat hypoglossal 
motoneurons where acute exposure to NO donors also increased excitability with no 
discernable change in input resistance (Gonzalez-Forero et al. 2007). These results  
indicate that NO can activate pharyngeal motoneurons, however the mechanism by 
which acute NO affects motoneuron excitability is undefined.  Based on these results it 
was postulated that NO has a pathological effect on hypoglossal neurons by 
contributing to excitotoxicity and neurodegeneration (Gonzalez-Forero et al. 2007). For 
example, if produced in excess, NO damages normal cells and contributes to the 
pathogenesis of motoneuron degeneration (Calabrese et al. 2007; Strijbos et al. 1996). 
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However, clearly sub-toxic levels of NO can mediate numerous physiological processes 
(Cavas & Navarro, 2006; Esplugues, 2002; Pierrefiche et al. 2007) . Therefore, we 
hypothesize that acute exposure to NO at physiological concentrations is not toxic; but 
rather confers a physiological signal to respiratory motoneurons during sleep to regulate 
activity in an adaptive, physiological capacity.     
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MATERIALS AND METHODS 
In vivo preparation.  
 All of the in vivo experiments were done by Dr. Richard Horner at the University 
of Toronto. The surgical procedures and experimental protocols were similar to those 
previously described (Steenland et al. 2008); (Sirois et al. 2002) and conform to 
recommendations of the Canadian Council on Animal Care. Briefly, isoflurane (2.2 – 
3.1%) anaesthetized adult rats (N=9) were instrumented with a microdialysis probe 
(CMA/11 14/01, CSC, St. Laurent, QC, CA) and electrodes to measure muscle 
(genioglossus and diaphragm) electromyogram (EMG) activity and cortical 
electroencephalogram (EEG) and genioglossus activity. The microdialysis probe will be 
placed into the HMN at the following coordinates: 13.7 ± 0.04 mm posterior to bregma,  
0.1 ± 0.02 mm lateral to the midline and 10.1 ± 0.03 mm ventral to bregma. A brief burst 
of tongue activity was used to determine correct probe placement in the HMN. At the 
end of each experiment, we confirmed probe placement in the HMN using histology and 
by evoking a characteristic response to serotonin. To record cortical EEG, we implanted 
wire electrodes onto the skull of the frontal-parietal cortex (Liu, Sood, Liu, & Horner, 
2005). To record genioglossus activity, we positioned two wire electrodes bilaterally 
under the body of the tongue (Horner R. L., 2007). All electrical signals including raw 
EEG and genioglossus activity will be amplified, fi ltered, digitized and recorded on a 
computer as previously described. For experiments in conscious animals, rats will be 
allowed ~1 week recovery from surgery.   
Microdialysis.   
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 During an experiment, the probe was continually perfused (2.0 ml min-1) with 
artificial cerebrospinal fluid (ACSF) of the following composition (mM): 125 NaCl, 3 KCl, 
1 KH2PO4, 2 CaCl2, 1 MgSO4, 25 NaHCO3, and 30 glucose; bubbled with 95% O2-5% 
CO2 to pH 7.42 ± 0.003. Each animal was perfused for 1-2 hours with ACSF to establish 
a stable baseline prior to testing the effects of the NO donor (DEA). Once a stable 
baseline has been established, the perfusion medium was switched to perfusate 
containing DEA (10 and 100 mM).There was a lag time of ~ 6 min and each drug 
exposure lasted 15 min; only data from the last min will be used for analyses.    
In vivo recording and analysis.   
 The electrical signals were amplified and filtered (Super-Z head-stage amplifiers 
and BMA-400 amplifiers/filters, CWE Inc., Ardmore, PA). The EEG was amplified and  
filtered between 1 and 100 Hz, whereas the EMG signals were amplified and fi ltered 
between 100 and 1000 Hz. The GG and diaphragm signals were recorded at the same 
amplification across all experiments. It was not necessary to alter the gain of the 
recording apparatus between experiments and baseline EMG activity was similar across 
rats. The electrocardiogram was removed from the diaphragm signal using an 
oscilloscope and electronic blanker (Model SB-1, CWE Inc.). In addition, the moving 
time averages (time constant= 100 ms) of the GG and diaphragm signals were obtained 
(Coulbourn S76-01, Lehigh Valley, PA, USA). Each signal, along with blood pressure 
(DT-XX transducer, Ohmeda, Madison, WI, USA and PM-1000 Amplifier, CWE Inc.) 
were digitized and recorded on computer (Spike 2 software, 1401 interface, CED Ltd., 
Cambridge, UK).   
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 Breath-by-breath measurements of GG and diaphragm activities were calculated 
and averaged in consecutive 5-sec time bins (Hajiha et al. 2009). All values were 
written to a spreadsheet and matched to the corresponding intervention at the HMN to 
provide a grand mean for each variable, for each intervention, in each rat. The EMG 
signals were analyzed from the moving time average signals (above electrical zero) and 
quantified in arbitrary units and expressed as a percentage (%) of the respective ACSF 
controls. GG activity was quantified as mean tonic activity (i.e. basal activity during 
expiration), peak activity and respiratory-related activity (i.e. peak inspiratory minus 
tonic activity). In practice there was no tonic GG activity in these experiments 
performed under anesthesia, so only respiratory-related GG activity is presented. Mean 
diaphragm amplitudes (i.e. respiratory-related diaphragm activity), respiratory rate and 
mean arterial blood pressure were also calculated for each 5-sec period. The EEG was 
sampled at 500 Hz and subjected to a fast-Fourier transform for each 5-sec time bin, and 
the power within frequency bands spanning the 0.5 to 30 Hz range was calculated. The 
ratio of high (2, 20-30 Hz) to low (1, 2-4 Hz) frequency activity was calculated and used 
as a relative marker of EEG activation (Steenland, Liu & Horner, 2008); (Hajiha et al. 
2009). Each rat served as its own control. The effects of DEA on each parameter of 
interest were compared by two-way RM-ANOVA using the Bonferroni corrected P 
value. Data are presented as means ± S.E.M. unless otherwise indicated.  
In vitro brain slice preparation.   
 Slices containing the HMN were prepared as previously described. All 
procedures were performed in accordance with National Institutes of Health and 
University of Connecticut Animal Care and Use Guidelines. Briefly, neonatal rats 
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(Sprague-Dawley, 7-12 days postnatal) were decapitated under ketamine/xylazine 
anesthesia and transverse brainstem slices (300 µm) cut using a microslicer (DSK 
1500E, Dosaka, Japan) in ice-cold substituted Ringer‟s solution containing (in mM): 260 
sucrose, 3 KCl, 5 MgCl2, 1 CaCl2, 1.25 NaH2PO4, 26 NaHCO3, 10 glucose, and 1 
kynurenic acid. Slices were incubated for ~30 minutes at 37ºC and subsequently at 
room temperature in normal Ringer‟s solution (in mM): 130 NaCl, 3 KCl, 2 MgCl2, 2 
CaCl2, 1.25 NaH2PO4, 26 NaHCO3, and 10 glucose. Both substituted and normal 
Ringer‟s solutions were bubbled with 95% O2/5% CO2.   
Slice-patch electrophysiology.   
 Individual slices were transferred to a recording chamber mounted on a fixed-
stage microscope (Zeiss Axioskop FS) and perfused continuously (~2 ml min-1) with a 
bath solution composed of (mM): 140 NaCl, 3 KCl, 2 MgCl2, 2 CaCl2, 10 N-2-
hydroxyethylpiperazin-N‟-2-ethanesulfonic acid (HEPES), 10 glucose; pH was adjusted 
between 6.9 and 7.5 by addition of HCl or NaOH. Hypoglossal motoneurons were 
visualized using differential interference optics and identified by their location (lateral 
and ventrolateral to the central canal) and by their characteristic size and shape (Sirois, 
Lynch, & Bayliss, 2002). All recordings were made with an Axopatch 200B patch-clamp 
amplifier, digitized with a Digidata 1322A analog-to-digital converter, and recorded using 
pCLAMP 10.0 software (Molecular Devices). Recordings were obtained at room 
temperature with patch electrodes pulled from borosilicate glass capillaries  (Warner 
Instruments Inc.) on a two-stage puller (Sutter  Instruments, P89) to a DC resistance of 
3–5 M  when filled with internal solution containing the following  (in mM): 120 KCH3SO3, 
4 NaCl, 1 MgCl2, 0.5 CaCl2, 10 HEPES,
 10 EGTA, 3 Mg-ATP, 0.2% biocytin, and 0.3 
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GTP-Tris, pH 7.2; electrode tips were coated with Sylgard 184. Voltage-clamp 
recordings were made at a holding potential of -60 mV and in the presence of 
tetrodotoxin (TTX, 0.1 µM). Exposure to DEA varied between 3-5 minutes durations with 
concentrations determined by generation of an EC50 (figure 2). We follow the time 
course of the NO induced changes in holding current and conductance with intermittent 
steps (0.2 Hz) to -100 mV. Current-voltage (I-V) relationships were determined for 
various treatment protocols from „instantaneous‟ currents (i.e. immediately following the 
capacitive transient, before activation of the time-dependent Ih current) obtained by 
hyperpolarizing the cell in 10 mV steps (to −150 mV). The maximal amplitude of Ih was 
quantified as the size of the time-dependent current during a 1 second long step to −150 
mV. A liquid junction potential of 10 mV was corrected off-line.   
Statistical Analysis. 
Data were reported as means ± SEM and were analyzed by  the paired t test or 
two-way RM-ANOVA followed by Bonferroni's multiple comparisons test when 
appropriate (p<0.05). Data are presented as means ± S.E.M. unless otherwise 
indicated.  
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Figure 2. Bath NO measurements.  Nitric oxide was measured polarographically 
(+860 mV).  A, trace of bath NO and summary data. B, show the level of NO produced 
by DEA.  C, trace of holding current shows that 1-100 µM DEA reversibly decrease 
holding current. D, average (N=5) DEA dose response curve. Note that our working 
DEA concentration (20 μM) is near the estimated EC50. 
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RESULTS 
 To test the hypothesis that NO helps maintain airway patency by increasing 
genioglossus activity, Dr. Horner applied Diethylamine NONOate (DEA/NO, a NO 
donor) to the HMN of anesthetized animals while recording genioglossus and 
diaphragm activity, blood pressure and respiratory rate. Under control conditions blood 
pressure averaged 75.7 ± 3.1 mmHg, respiratory-related GG and diaphragm muscle 
activities averaged 97.1 ± 17.8 and 689.7 ± 79.2 arbitrary units respectively, and 
respiratory rate averaged 47.5 ± 2.7 min-1. Microdialysis of DEA (10 mM) into the HMN 
caused a robust increase in GG activity with no change in amplitude of diaphragm 
activation or blood pressure (Fig 3A and B), i.e., the effects on GG activity were specific 
to the interventions at the hypoglossal motor pool and did not significantly affect these 
other variables. Likewise, there was no effect of DEA on the ratio of high (2, 20-30 Hz) 
to low (1, 2-4 Hz) EEG frequency activity (not shown). However, higher concentrations of 
DEA (100 mM) were not specific to the HMN as evidenced by the increase in respiratory 
rate (Fig 3B). In the brain slice preparation, exposure to 20 µM DEA, which corresponds 
with an NO concentration of 6.2 ± 0.4 µM (Fig S1A and B), depolarized membrane 
potential (7.1 ± 1 mV; N= 8) (in the presence of 0.1 µM TTX to block action potentials) 
and increased the firing rate response (in TTX free media) of hypoglossal motoneurons 
to depolarizing current injections (Fig. 3D-F) but with no parallel change in input 
resistance. Decomposed DEA that is no longer able to release NO had no effect, 
indicating that effects of DEA on hypoglossal motoneurons are mediated by NO rather 
than potential reactive byproducts. These results are consistent with reported effects of 
NO donors on trigeminal (Abudara et al. 2002) and hypoglossal motoneurons  
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Figure 3. NO functions as an excitatory transmitter in the HMN in vivo and in vitro.  
A, traces of blood pressure (BP) and integrated diaphragm and genioglossus (GG) 
EMG activity show that microdialysis of the NO donor (DEA, 10 mM) into the HMN of an 
anesthetized adult rat caused a doubling of respiratory-related GG activity with no 
change in other parameters of interest. B, summary of in vivo data (N=9) showing 
effects of 10 and 100 mM DEA on GG EMG, diaphragm EMG, BP, and respiratory rate.  
Note that a small increase in respiratory rate was observed in response to 100 mM 
DEA. C, slice-patch current-clamp recording of membrane potential shows that 
exposure to DEA (20 µM) reversibly depolarized membrane potential ~8 mV. D, 
summary of in vitro data (N=7) showing DEA-induced depolarization. E, steady-state 
frequency-current relationships under control conditions and in the presence of DEA 
show that DEA increases the firing rate response to depolarizing current injections > 
+190 pA. These results show that NO can stimulate hypoglossal motoneurons in vitro 
and increases airway patency in vivo.   
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(Montero et al. 2008), and suggest that NO increases excitability of hypoglossal 
motoneurons by modulating multiple channels, possibly inhibition of background TASK 
channels (Gonzalez-Forero et al. 2007) or activation of HCN channels (Abudara et al. 
2002). 
 To explore this possibility further, we made voltage-clamp recordings (holding 
potential of -60 mV; 0.1 µM TTX) from hypoglossal motoneurons during exposure to 
DEA under experimental conditions designed to block contributions of either TASK or 
HCN channels. In the first set of experiments, we found that DEA inhibited a resting K+ 
conductance when HCN channels were blocked with Cs+. For example, exposure to 
DEA in the continued presence of Cs+ decreased outward current and conductance by 
35.8 ± 2.4 pA (N=25) and 0.95 ± 0.06 nS (N=25), respectively (Fig. 4A1). The current-
voltage (I-V) relationship of the NO-sensitive current in Cs+ is reminiscent of TASK, i.e., 
relatively voltage-independent, active at resting membrane potential and reversed near 
EK (Fig 4A2). To confirm that TASK channels contribute to NO-sensitivity of hypoglossal 
neurons, we retested DEA in Cs+ this time in the presence of methanandamide, a 
blocker of TASK-1, TASK-3 and heteromeric TASK1/3 channels (Kim et al. 2009). 
Methanandamide (10 μM) decreased effects of DEA on holding current by 40% and 
virtually eliminated the residual NO-sensitive current in Cs+ (Fig. 4B1-3). In addition, we 
found that the selective soluble guanyl cyclase (sGC) blocker 1H-(1,2,4)oxadiozolo(4,3-
a)quinoxaline-1-one (ODQ, 10 µM) decreased effects of DEA on holding current and 
conductance (Fig. 4C1-3), thus indicating that the signaling pathway responsible for NO 
modulation of TASK channels in hypoglossal motoneurons. 
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Figure 4. NO inhibits a TASK-like conductance by a cGMP-dependent mechanism. 
A1, traces of holding current and conductance show that, in Cs+ (2 mM) to block HCN 
channels and tetraethyl-ammonium (TEA,10 mM) and 4-aminopyridine (4AP, 50 µM) to 
block voltage-gated K+ channels, exposure to DEA (20 µM) decreased outward current 
and conductance. A2, average (N=6) current-voltage (I-V) relationship of the NO-
sensitive current (determined by subtracting I-V relationships obtained during exposure 
to DEA from those recorded in the absence of DEA) in Cs+ is similar to a TASK-like 
conductance, i.e., relatively voltage-independent current that is active at resting 
membrane potential and reverses near the equilibrium potential for K+. A3, summary 
data (N=6) show DEA-induced change in holding current in Cs+ alone and in Cs+ with 
TEA and 4AP. B1, traces of holding current and conductance show that in Cs+ exposure 
to DEA decreases outward current and conductance. However, responsiveness to a 
second DEA exposure was reduced by methanandamide (Met, 10 μM), a TASK channel 
blocker. B2-B3, average I-V relationships in Cs+ alone and during exposure to DEA in 
Cs+ with and without Met. B4, summary data (N=6) showing that i n the continued 
presence of Cs+ subsequent inhibition of TASK channels with Met decreased the DEA-
induced change in holding current. C1, traces of holding current and conductance show 
that the sGC blocker ODQ (20 µM) decreased DEA sensitivity. The asterisk designates 
a 10 min break. C2-C3, average I-V relationships in Cs+ alone and during exposure to 
DEA in Cs+ with and without ODQ. C4, summary data (N=13) showing that ODQ 
decreased the DEA-sensitivity TASK-like conductance. These results strongly suggest 
that TASK channels contribute to NO-sensitivity of hypoglossal motoneurons by a 
cGMP-dependent mechanism.  
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These results are consistent with the reported effects of NO/cGMP on TASK channels 
in hypoglossal motoneurons (Gonzalez-Forero et al. 2007). 
 Hypoglossal neurons also express HCN channels which can be directly activated 
by cGMP so we considered the possibility that the hyperpolarization activated current 
(Ih) generated by HCN channels also contributes to NO-sensitivity of hypoglossal 
neurons. To study NO modulation of HCN channels in relative isolation, we used Ba2+ 
(2 mM) to block background K+ channels (i.e., TASK) with minimal effect on HCN 
channels (Biel et al. 2009). Under these conditions exposure to DEA decreased holding 
current by 60.3 ± 3.1 pA (N= 20) and increased conductance by 1.32 ± 0.1 nS (N= 20), 
indicating that DEA/NO activated an inward current (Fig. 5A) with ODQ (20 µM) (Fig. 
5A), suggesting that DEA-sensitivity is not dependent on formation of cGMP. In 
addition, effects of Cs+ on holding current and conductance were 94.7 ± 22% and 75.4 ± 
8.3% (N=9; Fig. 5A) larger in DEA plus Ba2+ compared to Ba2+ alone, indicating that 
DEA/NO activates a Cs+-sensitive inward current similar to Ih. To determine the effects 
of DEA on time- and voltage-dependent properties of Ih, we delivered 1 second long 
hyperpolarizing voltage steps from -60 to -150 mV (Δ 10 mV). The DEA difference 
current, generated by subtracting current responses to hyperpolarizing voltage steps 
recorded in DEA plus Ba2+ from those recorded in Ba2+ alone, show that DEA 
preferentially increased Iinst with little change in the time dependent component of Ih 
(Fig. 5B). This can also be seen in summary data plotted as amplitude of total Ih at -150 
mV (Fig. 5F) or as the ratio of Iinst/Iss across voltages ranging from -60 to -150 mV 
(Fig. 5G). 
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Figure 5. NO selectively activates Iinst. A, traces of holding current and conductance 
show that in Ba2+ (2 mM) to block background K+ channels, exposure to DEA (20 µM) 
decreased outward current and increased conductance. In addition, DEA increased 
effects of Cs+ on holding current and conductance by 55% and 58% (N=9), indicating 
that DEA increased a Cs+-sensitive inward current. Inset, Cs+-sensitive difference 
currents, generated by subtracting current responses to hyperpolarizing voltage steps 
recorded at the indicated times (scale bars are 500 ms and 500 pA). B, current 
responses to hyperpolarizing voltage-steps recorded in Ba2+ alone, Ba2+ plus DEA, and 
the corresponding difference current show that DEA preferentially increases Iinst with 
little change in Iss. This can also be seen in the superimposed current responses to a -
150 mV step in Ba2+ alone and Ba2+ plus DEA plotted in the lower portion of panel B. C, 
traces of holding current and conductance show that DEA was without effect when 
background K+ channels are blocked with Ba2+ (2 mM) and HCN channels are blocked 
with the selective HCN channel blocker ZD7288 (50 µM). D, summary data showing 
effects of DEA on conductance in Ba2+ alone (N=7) and Ba2+ plus ZD7288 (N=7). E, 
Iinst evoked by hyperpolarizing voltage steps in Ba2+ alone and in Ba2+ plus DEA. The 
data were fitted with linear regression and the extrapolated intersection of the 
regression lines is near the reversal potential for Ih. F, average Ih amplitude plotted as 
Iinst and Iss evoked by a -150 mV step in Ba2+ alone (N=8), Ba2+ plus DEA (N=8), and 
Ba2+ plus DEA and Cs+ (N=3) or ZD7288 (N=5). G, average Ih amplitude plotted as a 
ratio of Iinst/Iss across voltages ranging from -60 to -150 mV. Note that decomposed 
DEA was without effect (not shown), indicating that DEA responses are mediated by NO 
rather than reactive byproducts.  
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The I-V relationships of Iinst in Ba2+ alone and in Ba2+ plus DEA intersect near the 
reversal potential for HCN channels (Fig 5E) and the effects of DEA were completely 
blocked with ZD7288 (50 μM), a selective HCN channel blocker (Fig 5C-D). These are 
the first evidence that NO can preferentially increase instantaneous Ih and in doing so 
have profound effects on neuronal excitability.  
 The results described above differ from known effects of cyclic nucleotides on 
HCN channels (Biel et al. 2009); therefore we postulate that this novel form of HCN 
channel modulation is conferred a cGMP-independent mechanism involving S-
nitrosylation. Consistent with this possibility, we found that effects of DEA (in Ba2+) on 
holding current and conductance were fully retained when activity of sGC was blocked 
There are no selective blockers of S-nitrosylation signaling, however, this is a reduction-
oxidation (REDOX) pathway that requires the thiol group of cysteine residues to be in 
the reduced state. Therefore, we used oxidative stress in the form of hyperoxia (95% 
O2) or the cysteine specific oxidant N-ethylmaleimide (NEM; 300 µM) to oxidize 
cysteine residues and thus occlude subsequent S-nitrosylation. We found that 
hyperoxia (N=8) and NEM (N=4) decreased the DEA-induced inward current by 69.6 ± 
3.2% and 69 ± 3%, respectively (Fig. 6B). In addition, we used uric acid, the most 
abundant plasma antioxidant and preferential scavenger of NO (Gersch et al. 2008), to 
buffer NO and limit S-nitrosylation signaling. We found that uric acid (1 mM, pH = 7.3) 
decreased DEA-induced inward current by 54.3 ± 3.6 % (N=7) (Fig. 6C).  Together, 
these results strongly suggest that NO increases instantaneous Ih by an S-nitrosylation 
dependent mechanism. It is important to note that the level of hyperoxia used here to 
block S-nitrosylation signaling is commonly used to set control PO2 in many in vitro 
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Figure 6. NO modulates HCN channels by an S-nitrosylation dependent 
mechanism.  A, traces of holding current and conductance show that exposure to DEA 
in Ba2+ activated an inward current with properties similar to Ih (Fig. 3). In the continued 
presence of Ba2+ subsequent inhibition of sGC with ODQ did not affect DEA-sensitivity. 
Bar graph on right shows summary data (N=5) plotted as DEA-induced change in 
holding current in Ba2+ alone and Ba2+ plus ODQ. B, traces of holding current and 
conductance show the characteristic DEA response in Ba2+. A second exposure to DEA 
after 7 mins of incubation in hyperoxic (95% O2) medium this time had no effect on 
holding current or conductance. In addition, the cysteine specific oxidant NEM (300 µM) 
also decreased DEA-sensitivity, suggesting that the inward current activated by NO 
(i.e., Iinst; Fig. 3) is mediated by S-nitrosylation-dependent signaling. C, traces of 
holding current and conductance show that uric acid (1 mM), antioxidant and 
preferential scavenger of NO, decreased the effects of DEA.    
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preparations (Mulkey et al. 2001). Our evidence indicates that under these conditions 
NO-mediated S-nitrosylation would not occur, and so it is not surprising that this novel 
form of HCN channel modulation has not been previously observed. 
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DISCUSSION 
 In this study, we tested the hypothesis that NO increased excitability of 
hypoglossal motoneurons in vivo and in vitro. Our results indicate that NO increased 
activity of hypoglossal motoneurons by a cGMP-dependent inhibition of TASK channels. 
We also demonstrated that HCN channels are activated in a cGMP-independent 
manner, specifically the Iinst component of Ih is selectivly activated by an S-nitrosylation 
dependent mechansim. We also show that NO increases activity of hypoglossal 
motoneurons in vitro and increases tongue activity in vivo. These observations are 
consistent with the possiblity that NO may help maintain airway patency.    
 Our in vivo data strongly suggests that NO activates hypoglossal neurons and 
increases genioglossus activity. Micro-perfusion of DEA into the HMN of anesthetized 
rats increased tongue activity consistent with no effect on respiratory rate or EEG.  As 
described previously, during wakefulness the HMN receives 5HT and NE drive that 
increased excitability of hypoglossal motoneurons. Therefore, we proposed that 
regardless of arousal state (i.e., in the presence of wakeful transmitters or sleep-
activated NO/cGMP signaling), exogenous application of NO donors will activate 
hypoglossal neurons and increase genioglossus activity.  
 A limitation associated with the micro-perfusion preparation is that it typically 
requires 10-100 times higher drug concentrations then used in vitro because of reduced 
tissue access and limited drug diffusion across the probe membrane (Chan, Steenland, 
Liu, & Horner, 2006). Despite the use of high drug concentrations, previous studies 
show that there is minimal spreading of drugs to the adjacent nucleus and effects are 
restricted to the HMN (Chan, Steenland, Liu, & Horner, 2006). We did however see an 
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increase in respiratory rate with 100 mM DEA. With such high concentrations of NO 
donor, it is entirely possible to have uncontrolled diffusion to other respiratory centers. It 
should also be noted that application of exogenous NO donors does not exactly mimic 
the transient and discrete synthesis of NO by activated nNOS-expressing fibers in the 
HMN. Nevertheless, these experiments support our in vitro experiments that will be 
discussed shortly and confirm that NO can modulate activity of the HMN in vivo.   
 We also showed in vitro, NO donors depolarized motoneuron membrane 
potential and increased excitability with no overall change in input resistance. Increased 
excitability in conjunction with no change in input resistance strongly suggests that NO 
is having opposing effects on the conductance two or more channels.  Indeed, we show 
that NO inhibits a resting K+ channel and activates an inward cesium-sensitive current 
similar to Ih.   
 Nitric oxide can affect neuronal excitability by cGMP-dependent and cGMP-
independent mechanisms. Cyclic GMP-dependent signaling can involve activation of 
PKG (PKG-I or PKG-II) and phosphorylation of serine and/or threonine residues on 
target proteins (e.g., background K+ channels), or direct activation of HCN channels that 
produce Ih current. We showed that the potential contribution of HCN, identified 
pharmacologically by inhibition with ZD7288, decreased the effects of NO on membrane 
potential and excitability of hypoglossal neurons. In addition, hypoglossal neurons also 
express a TTX-insensitive persistent Na+-current (Fenik & Veasey, 2003) and evidence 
suggests that NO can activate persistent Na+ channels in cardiac myocytes by a cGMP-
independent mechanism involving S-nitrosylation (Ahern, Klyachko, & Jackson, 2002)  
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 The cGMP-independent pathway is a reduction-oxidation mechanism involving 
S-nitrosylation of sulfhydryl groups (e.g., cysteine amino acids) on target proteins 
including ion channels or second messenger signaling molecules (Ahern, Klyachko, & 
Jackson, 2002). There are no known specific blockers of S-nitrosylation which makes it 
a difficult thing to test in an in vitro or in vivo system. The process of S-nitrosylation can 
be disrupted by increased oxidative stress in the external environment. High oxidative 
stress would oxidize the sulfhydryl groups of the cysteine which would prevent the 
nitrosothiol from forming. We exposed the hypoglossal neurons to 95% O2 and 
subsequently applied DEA which had a much smaller effect than the control. We also 
demonstrated that the DEA effect in the presence of the sulfhydryl blocker, NEM was 
greatly decreased as well. Collectively, our data shows that the DEA response was 
occluded in the presense of oxidative stresses supporting the prospect that a S-
nitrosylation mechanism is involved. Our data demonstrates that acute NO exposure 
with HCN channels has different effects on hypoglossal neurons by cGMP-independent 
mechanism which we believe is S-nitrosylation. 
 Another potential method to block S-nitrosylation is the presence of plasma 
antioxidants, the most abundant of which is uric acid. Uric acid comes into contact with 
NO forming 6-aminouracil which then depletes plasma NO levels (Gersch et al. 2008). 
The uric acid buffering system works preferentially for NO rather than other radicals, 
such as peroxynitrite (Gersch et al. 2008). A uniqure property of uric acid is that is can 
also act as a prooxidant in conditions where oxidative stresses are imposed (Gersch et 
al. 2008). Our data shows a diminished effect of DEA in the presence of uric acid. 
Perhaps an individual with elevated uric acid levels which is the cause in gout, have a 
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greater predisposition to OSA. It would therefore be beneficial to clinically use xanthine 
oxidase inhibitors which have been shown to lower uric acids levels (Gersch et al. 
2008). In the future, further studies into using xanthine oxidase inhibitors, possibly in 
conjunction with NO donors could amerloriate the patholgical effects of OSA.   
 Ih is composed of an instantaneous (Iinst) and steady state component (Iss). It 
has been documented that these components of the channel can be modulated 
independently of one another (Liang et al. 2009). A study has shown that mutation of 
the S4 domain of the HCN2 isform in cell culture diminished overall Ih while leaving the 
Inst component unaffected (Proenza et al. 2001). This modulation could result by 
differential gating of one population of HCN channels. Consistent with this data, we 
demonstrated that application of our NO donor increased the Iinst component 
independently of the overall Ih.  
 The results from experiments on the effects of NO and cGMP signaling on 
hypoglossal neurons in brain slices will provide strong evidence that NO can increase 
excitability of hypoglossal neurons by a cGMP-mediated inhibition of a background K+ 
channel and cGMP-independent activation of HCN channels. All in vitro experiments 
were conducted in the medullary brain slice preparation because it allows considerable 
control of the neuronal environment and easy access to neurons for patch clamp 
recording. However, it is important to recognize that the brain slice preparation has 
several limitations. Perhaps most importantly, slices are removed from a blood supply 
and receive O2 and nutrients solely by diffusion from the bath. Therefore, most brain 
slice studies use bath solutions saturated with O2 (95% O2), and consequently subject 
cells on the surface of the slice to nonphysiologically high O2 tension. High O2 at the 
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slice surface, where most patch clamp recordings are made, may interfere with NO 
signaling; especially S-nitrosylation signaling which requires sulfhydryl groups to be in 
the reduced state. However, we used that to our advantage to show that oxidizing the 
sulfhydryl groups decreased the responsiveness to NO exposure. Other limitations of 
the slice preparation include traumatized tissue and a lack of most network connections, 
as well as effector muscles. Despite these limitations, the brain slice preparation is 
considered well suited for characterizing intrinsic properties of neurons as well as 
inspiratory drive to the HMN. 
 The effects of hypoxia on NO-mediated modulation of TASK channels are 
particularly interesting in the context of OSA where hypoxia (which results from OSA) 
may disrupt NO signaling and contribute to the onset of sleep disordered breathi ng. The 
mechanism by which hypoxia inhibits TASK channels may be linked to decreased ATP 
production and/or activation of AMP-activated protein kinase (AMPK) but our lab has 
shown that activation of AMPK does not affect activity of TASK-1 or TASK-3 channels 
(Kreneisz et al. 2009). We see more of an involvement of HCN channels when exposed 
to DEA as opposed to TASK. We have an alternative hypothesis which contends that 
reactive oxygen species (ROS) and reactive nitrogen species (RNS) produced during 
hypoxia can cause the oxidation of cysteine residues on HCN channels resulting in 
decreased channel activity. In addition, ROS (e.g., superoxide) can react with NO to 
form peroxynitrite (Esplugues, 2002), a highly reactive and toxic ROS. Therefore, it is 
possible that peroxynitrite will be formed during periods of intermittent hypoxia and 
contributes to motoneuron damage associated with OSA. In the future, we plan to 
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explore potential interaction between hypoxia and NO on native TASK channels and 
hypoglossal motoneurons in the brain slice preparation.   
 It is our hope that these results help establish a novel modulatory role of NO in 
the HMN that may contribute to the state-dependent control of airway patency. 
Specifically, we determine that i) NO increased excitability of genioglossus in the in vivo 
animal; ii) NO activates hypoglossal neurons by inhibition of a background K+ channel 
by a cGMP-dependent pathway; iii) NO depolarizes hypoglossal neurons by activation 
of an inward HCN like current by a cGMP-independent pathway by shifting Iss to Iinst. 
CONCLUSION 
 Our results indicate that NO selectively increases Iinst by an S-nitrosylation-
dependent mechanism. Considering that the HMN receives nitrergic innervation from 
the sleep-activated cholinergic system (Vincent & Kimura, 1992), this signaling pathway 
may partially compensate for loss of wakeful excitatory drive to respiratory motoneurons 
during sleep; conversely disruption of NO signaling may contribute to the etiology of 
obstructive sleep apnea (OSA). Although a causal link between disruption of NO 
signaling and OSA has yet to be established, it is well known that patients with 
metabolic syndrome have high levels of uric acid and, perhaps consequently, have a 
high prevalence of OSA (Mota, 2010). In addition, this novel mechanism may also 
influence HCN channels in cardiac pacemaker cells since NO has been shown to 
stimulate heart rate by activation of Ih (Musialek et al. 1997). 
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